Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma
Xiaomao Yin, Zaoyu Wang, Jianfeng Wang, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Cancer immunotherapy with immune checkpoint inhibitors (ICIs): potential, mechanisms of resistance, and strategies for reinvigorating T cell responsiveness when resistance is acquired
Hany E. Marei, Anwarul Hasan, Giacomo Pozzoli, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 114
PD1/PD-L1 blockade in clear cell renal cell carcinoma: mechanistic insights, clinical efficacy, and future perspectives
Zhu Zhao-yang, Yigang Jin, Jing Zhou, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 11
Efficacy and toxicity of immune checkpoint inhibitors combination therapy for advanced renal cell carcinoma: a systematic review and network meta-analysis
Xiangyu Chen, Zhunan Xu, Changgui Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
Hongquan Chen, Renxi Lin, Weibin Lin, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 19
Assessing the role of programmed cell death signatures and related gene TOP2A in progression and prognostic prediction of clear cell renal cell carcinoma
Qingshui Wang, Jiamin Liu, Ruiqiong Li, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Multi-omics analysis reveals the panoramic picture of TOP2A in pan-cancer
Jin Zhang, Tianxiao Yang, Kenie Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
An Integrated Bioinformatics Analysis towards the Identification of Diagnostic, Prognostic, and Predictive Key Biomarkers for Urinary Bladder Cancer
Michail Sarafidis, George Ι. Lambrou, Vassilis Zoumpourlis, et al.
Cancers (2022) Vol. 14, Iss. 14, pp. 3358-3358
Open Access | Times Cited: 18
Crosstalk Between Metabolism and Immune Activity Reveals Four Subtypes With Therapeutic Implications in Clear Cell Renal Cell Carcinoma
Yi Wang, Xinde Zheng, Gui‐Qi Zhu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
Development of a Phagocytosis-Dependent Gene Signature to Predict Prognosis and Response to Checkpoint Inhibition in Clear-Cell Renal Cell Carcinoma
Kunping Li, Yuqing Li, Yinfeng Lyu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
A novel gene signature related to oxidative stress predicts the prognosis in clear cell renal cell carcinoma
Sheng Ma, Yue Ge, Zezhong Xiong, et al.
PeerJ (2023) Vol. 11, pp. e14784-e14784
Open Access | Times Cited: 8
Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma
Wei Bao, Qianguang Han, Xiao Guan, et al.
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2023) Vol. 31, Iss. 2, pp. 181-192
Open Access | Times Cited: 7
PD-1 Relevant Genes Predict the Prognosis of Breast Cancer and Their Prediction Effect in Tumor Response to Immunotherapy
Xiao Yu, Jianping Jiang, Yan Chen, et al.
ONCOLOGIE (2022) Vol. 24, Iss. 4, pp. 729-742
Open Access | Times Cited: 11
Machine learning–based integration develops a stress response stated T cell (Tstr)–related score for predicting outcomes in clear cell renal cell carcinoma
Shuai Yang, Zhaodong Han, Zeheng Tan, et al.
International Immunopharmacology (2024) Vol. 132, pp. 112017-112017
Open Access | Times Cited: 2
FOXM1 transcriptional regulation
Mengxi Li, Xuzheng Gao, Yanting Su, et al.
Biology of the Cell (2024) Vol. 116, Iss. 9
Closed Access | Times Cited: 2
Prognostic prediction of clear cell renal cell carcinoma based on lipid metabolism-related lncRNA risk coefficient model
Genyi Qu, Lu Liu, Lai Yi, et al.
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 6
Macrophage-Specific Cathepsin as a Marker Correlated with Prognosis and Tumor Microenvironmental Characteristics of Clear Cell Renal Cell Carcinoma
Fan Zhang, Jiayu Liang, You Lü, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 6275-6292
Open Access | Times Cited: 8
Prognostic value of programmed cell death ligand 1 expression in patients with intrahepatic cholangiocarcinoma: a meta-analysis
Feng Xian, Dacheng Ren, Jun Bie, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Network analysis of histopathological image features and genomics data improving prognosis performance in clear cell renal cell carcinoma
Jianrui Ji, Yunsong Liu, Yongxing Bao, et al.
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 8, pp. 249.e1-249.e11
Closed Access | Times Cited: 1
Predicting CTLA4 expression and prognosis in clear cell renal cell carcinoma using a pathomics signature of histopathological images and machine learning
Xiaoqun Yang, Xiangyun Li, Haimin Xu, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e34877-e34877
Open Access | Times Cited: 1
Prognostic significance of immune evasion-related genes in clear cell renal cell carcinoma immunotherapy
Tingxuan Huang, Yulu Peng, Ruiqi Liu, et al.
International Immunopharmacology (2024) Vol. 142, pp. 113106-113106
Closed Access | Times Cited: 1
Identification of a claudin-low subtype in clear cell renal cell carcinoma with implications for the evaluation of clinical outcomes and treatment efficacy
Cuijian Zhang, Yifan Li, Jinqin Qian, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 6
Prognostic prediction and immunotherapy response analysis of the fatty acid metabolism-related genes in clear cell renal cell carcinoma
Qinfan Yao, Xiuyuan Zhang, Chunchun Wei, et al.
Heliyon (2023) Vol. 9, Iss. 6, pp. e17224-e17224
Open Access | Times Cited: 3
A novel immune-related gene signature for predicting immunotherapy outcomes and survival in clear cell renal cell carcinoma
Jie Gu, Xiaobo Zhang, ZhangZhe Peng, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Integrative analysis of multi-omics data for discovery of ferroptosis-related gene signature predicting immune activity in neuroblastoma
Jiajian Hu, Fengju Song, Wenjuan Kang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
A bioinformatics-based immune-related prognostic index for lung adenocarcinoma that predicts patient response to immunotherapy and common treatments
Chenghao Wang, Tong Lu, Ran Xu, et al.
Journal of Thoracic Disease (2022) Vol. 14, Iss. 6, pp. 2131-2146
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top